Clinical Trial Update: Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical Study [Phase 2]

View source ↗

Summary

This document describes a Phase II prospective, open-label, single-arm trial evaluating nanocrystalline megestrol acetate for cancer-associated anorexia-cachexi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-associated Anorexia-cachexia Syndrome
• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Nanocrystalline Megestrol Acetate (megestrol acetate)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Extensive-stage Small Cell Lung Cancer (ES-SCLC), Cancer - Associated Anorexia - Cachexia Syndrome | Phase 2 | Status: NOT_YET_RECRUITING